Cargando…

Targeting human respiratory syncytial virus transcription anti-termination factor M2-1 to inhibit in vivo viral replication

Human respiratory syncytial virus (hRSV) is a leading cause of acute lower respiratory tract infection in infants, elderly and immunocompromised individuals. To date, no specific antiviral drug is available to treat or prevent this disease. Here, we report that the Smoothened receptor (Smo) antagoni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bailly, B., Richard, C.-A., Sharma, G., Wang, L., Johansen, L., Cao, J., Pendharkar, V., Sharma, D.-C., Galloux, M., Wang, Y., Cui, R., Zou, G., Guillon, P., von Itzstein, M., Eléouët, J.-F., Altmeyer, R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872165/ https://www.ncbi.nlm.nih.gov/pubmed/27194388 http://dx.doi.org/10.1038/srep25806

Ejemplares similares

Visualizing the replication of respiratory syncytial virus in cells and in living mice
por: Rameix-Welti, Marie-Anne, et al.
Publicado: (2014)

Structural landscape of the respiratory syncytial virus nucleocapsids
por: Gonnin, Lorène, et al.
Publicado: (2023)

The Insertion of Fluorescent Proteins in a Variable Region of Respiratory Syncytial Virus L Polymerase Results in Fluorescent and Functional Enzymes But with Reduced Activities
por: Fix, Jenna, et al.
Publicado: (2011)

Screening antivirals with a mCherry-expressing recombinant bovine respiratory syncytial virus: a proof of concept using cyclopamine
por: Fix, Jenna, et al.
Publicado: (2023)

A dual drug regimen synergistically blocks human parainfluenza virus infection
por: Bailly, Benjamin, et al.
Publicado: (2016)

Minimal Elements Required for the Formation of Respiratory Syncytial Virus Cytoplasmic Inclusion Bodies In Vivo and In Vitro
por: Galloux, Marie, et al.
Publicado: (2020)

The respiratory syncytial virus nucleoprotein–RNA complex forms a left-handed helical nucleocapsid
por: Bakker, Saskia E., et al.
Publicado: (2013)

Importance of RNA length for in vitro encapsidation by the nucleoprotein of human respiratory syncytial virus
por: Gonnin, Lorène, et al.
Publicado: (2022)

Functional organization of cytoplasmic inclusion bodies in cells infected by respiratory syncytial virus
por: Rincheval, Vincent, et al.
Publicado: (2017)

Interferon-Induced Protein 44 and Interferon-Induced Protein 44-Like Restrict Replication of Respiratory Syncytial Virus
por: Busse, D. C., et al.
Publicado: (2020)

Hardening of Respiratory Syncytial Virus Inclusion Bodies by Cyclopamine Proceeds through Perturbation of the Interactions of the M2-1 Protein with RNA and the P Protein
por: Diot, Cédric, et al.
Publicado: (2023)

Targeting the Respiratory Syncytial Virus N(0)-P Complex with Constrained α-Helical Peptides in Cells and Mice
por: Galloux, Marie, et al.
Publicado: (2020)

A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading
por: Gaillard, Vanessa, et al.
Publicado: (2017)

Single-Stranded Oligonucleotide-Mediated Inhibition of Respiratory Syncytial Virus Infection
por: Pålsson, Sandra Axberg, et al.
Publicado: (2020)

Retinoic Acid–Inducible Gene I Activation Inhibits Human Respiratory Syncytial Virus Replication in Mammalian Cells and in Mouse and Ferret Models of Infection
por: Schwab, Lara S U, et al.
Publicado: (2022)

Level of maternal antibodies against respiratory syncytial virus (RSV) nucleoprotein at birth and risk of RSV very severe lower respiratory tract infection
por: Receveur, Matthieu, et al.
Publicado: (2022)

The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection—suramin inhibits EV71 infection in vitro and in vivo
por: Ren, Peijun, et al.
Publicado: (2014)

Viral surface glycoproteins in carbohydrate recognition: Structure and modelling
por: Dyason, Jeffrey C., et al.
Publicado: (2010)

Structure and Functional Analysis of the RNA- and Viral Phosphoprotein-Binding Domain of Respiratory Syncytial Virus M2-1 Protein
por: Blondot, Marie-Lise, et al.
Publicado: (2012)

Viral N(6)-methyladenosine upregulates replication and pathogenesis of human respiratory syncytial virus
por: Xue, Miaoge, et al.
Publicado: (2019)

Reduction of influenza virus-induced lung inflammation and mortality in animals treated with a phosophodisestrase-4 inhibitor and a selective serotonin reuptake inhibitor
por: Sharma, Geeta, et al.
Publicado: (2013)

Optimization of the Codon Pair Usage of Human Respiratory Syncytial Virus Paradoxically Resulted in Reduced Viral Replication In Vivo and Reduced Immunogenicity
por: Le Nouën, Cyril, et al.
Publicado: (2020)

Interactions between the Nucleoprotein and the Phosphoprotein of Pneumoviruses: Structural Insight for Rational Design of Antivirals
por: Decool, Hortense, et al.
Publicado: (2021)

The N-Terminal of Aquareovirus NS80 Is Required for Interacting with Viral Proteins and Viral Replication
por: Zhang, Jie, et al.
Publicado: (2016)

Biochemistry of the Respiratory Syncytial Virus L Protein Embedding RNA Polymerase and Capping Activities
por: Sutto-Ortiz, Priscila, et al.
Publicado: (2023)

RSV hijacks cellular protein phosphatase 1 to regulate M2-1 phosphorylation and viral transcription
por: Richard, Charles-Adrien, et al.
Publicado: (2018)

Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication
por: Murray, Jackelyn, et al.
Publicado: (2022)

Ginseng Protects Against Respiratory Syncytial Virus by Modulating Multiple Immune Cells and Inhibiting Viral Replication
por: Lee, Jong Seok, et al.
Publicado: (2015)

Evaluation of Small Molecule Combinations against Respiratory Syncytial Virus In Vitro
por: Gao, Yuzhen, et al.
Publicado: (2021)

Host and Viral Factors in Respiratory Syncytial Virus Infection
por: Mastrangelo, Peter, et al.
Publicado: (2013)

Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2–ACE2 Receptor Interactions
por: Day, Christopher J., et al.
Publicado: (2021)

Activation of protein kinase R is required for induction of stress granules by respiratory syncytial virus but dispensable for viral replication
por: Lindquist, Michael E., et al.
Publicado: (2011)

Determination of Host RNA Helicases Activity in Viral Replication
por: Sharma, Amit, et al.
Publicado: (2012)

Discovery of a Novel Respiratory Syncytial Virus Replication Inhibitor
por: Wang, Li, et al.
Publicado: (2021)

Respiratory Syncytial Virus and Cellular Stress Responses: Impact on Replication and Physiopathology
por: Cervantes-Ortiz, Sandra L., et al.
Publicado: (2016)

The Interactome analysis of the Respiratory Syncytial Virus protein M2-1 suggests a new role in viral mRNA metabolism post-transcription
por: Bouillier, Camille, et al.
Publicado: (2019)

Viral Replication
por: FENNER, FRANK, et al.
Publicado: (1987)

Exploiting Connections for Viral Replication
por: Wong, Louise H., et al.
Publicado: (2021)

The mechanism of DNA replication termination in vertebrates
por: Dewar, James M., et al.
Publicado: (2015)

Structure of the Respiratory Syncytial Virus Polymerase Complex
por: Gilman, Morgan S.A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_aj2gpnkeji4d27o0l10favc4em